David Tran Joins PAC as Vice President of Product Management and Marketing

Houston, TX., USA –– PAC, a leading global provider of advanced analytical instruments for laboratories and online process applications, is pleased to announce that David Tran has now joined the growing PAC team as the Vice President of Product Management & Marketing. David has over thirty years of experience both within the petroleum industry and [...]

Cepheid Announces Update On Xpert® Test Availability

SUNNYVALE, Calif., --Ahead of its presentation at the JP Morgan Healthcare Conference in San Francisco later today, Cepheid (Nasdaq: CPHD) this morning shared an update on Xpert test availability, highlighting that significant progress towards a return to normal manufacturing operations was achieved despite higher than anticipated demand for a number of Xpert test products during [...]

Oxford Nanopore announces further collaborations for nanopore sensing technology

Oxford Nanopore Technologies, the leading developer of nanopore sensing technology for the analysis of DNA, RNA, proteins and other single molecules, announces that it has completed a series of agreements with leading academic research institutions including University of Illinois at Urbana-Champaign, Brown University, Stanford University, Boston University, University of Cambridge and University of Southampton. Oxford [...]

Beckman Coulter Life Sciences Features Genomic, Cellular Solutions at SLAS2013

INDIANAPOLIS, IND. –– Bringing together genomic and cellular sample preparation with integrated solutions to highlight their Automation with a Human Touch theme, Beckman Coulter Life Sciences will offer two workshops and present workstations addressing a range of applications in booth 921 when SLAS2013 convenes in Orlando, Fla., from January 12-16. Workshops offered by the company [...]

Illumina Announces Sequencing Technology Innovations

SAN DIEGO -- Illumina (NASDAQ: ILMN) today announced a series of product and technology innovations for its powerful sequencing ecosystem – from sample preparation to system enhancements to data analysis –– that will enable the next breakthroughs in understanding the genome. “Illumina has consistently led the market in conceptualizing, developing, and executing on industry-changing sequencing [...]

HighRes Biosolutions delivers state-of-the-art ultra-high-throughput drug screening system to Pivot Park Screening Centre, The Netherlands

Pivot Park Screening Centre (Oss, Netherlands) has recently taken delivery of a flexible laboratory automation system from HighRes Biosolutions, forming the core of its newly implemented ultra-high-throughput screening (uHTS) facility. Pivot Park Screening Centre will use the uHTS system to perform biochemical and cell-based screening assays to support research programs across public and private partnerships. [...]

Danaher CEO Comments on Outlook

Washington, D.C.,- Danaher Corporation (NYSE:DHR) announced that its President and Chief Executive Officer, H. Lawrence Culp, Jr., will comment tomorrow on the Company's performance in a presentation at the J.P. Morgan Healthcare Conference in San Francisco, CA. Mr. Culp will communicate that the Company's fourth quarter 2012 diluted net earnings per share is anticipated to [...]

IntelligentMDx Enters into an Agreement with QIAGEN to Develop and Manufacture Molecular Tests

CAMBRIDGE, MASSACHUSETTS –— IntelligentMDx (privately held) announced today that it has entered into a multi-year development and license agreement with QIAGEN (NASDAQ: QGEN, Frankfurt Prime Standard: QIA) to design, develop and manufacture several undisclosed CE-marked and FDA cleared diagnostic tests for use on QIAGEN's flagship QIAsymphony RGQ automated platform. Financial terms have not been disclosed. [...]

Rolland Carlson, Ph.D. named CEO of Asuragen

Austin, Texas – Asuragen Inc., a leading molecular diagnostic company, announced today that Rollie Carlson, previously the President and Chief Operating Officer of the Company, has been appointed President and CEO. Matt Winkler, the founder and prior CEO of Asuragen, will retain the role of Chairman of the Board and Chief Scientific Officer. "I had [...]

Labcyte and FIMM Announce a Collaboration Enabling “Real-Time” Science to Advance Personalized Medicine in Cancer Treatments

SUNNYVALE, Calif. & HELSINKI -- Labcyte Inc. and the Institute for Molecular Medicine Finland (FIMM) are collaborating to further the development of personalized medicine in cancer treatment. Labcyte acoustic liquid handling technology has already revolutionized small-molecule research. Now, FIMM, a European leader in advanced research for new cancer therapies, will apply the technology extensively in [...]

Access IBO on Knowledge Center